GGrantIndex
Sort

23,748 grants matching melanoma

Oncogenic Events in Thyroid Neoplasia

$449,000
James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY

$448,985
Robert David Schreiber · Washington University · R01 · FY2016 · CA

Strategies to improve the adoptive transfer of T cells

$448,945
Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA

Understanding and improving novel oncolytic viruses for pancreatic cancer

$448,536
Valery Zurabovich Grdzelishvili · University Of North Carolina Charlotte · R15 · FY2024 · CA

Promoting Bim-driven apoptosis through MAPK inhibition: A therapeutic strategy in advanced melanoma

$448,463
Ryan J Sullivan · Massachusetts General Hospital · R01 · FY2018 · CA

Transport Oncophysics Core

$448,357
Haifa Shen · Methodist Hospital Research Institute · U54 · FY2018 · CA

Deciphering the tumor suppressive functions of macroH2A

$448,328
Emily Bernstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA

Deciphering the tumor suppressive functions of macroH2A

$448,328
Emily Bernstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA

The Genetics of Susceptibility to Mouse Plasma Cell Tumors

$448,310
Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome

$448,226
Jennifer A. Wargo · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA

Chemical Probes to Study Copper Biology

$448,138
Christopher J. Chang · Princeton University · R01 · FY2024 · GM

Androgen receptor function in melanoma

$448,034
Gian Paolo Dotto · Massachusetts General Hospital · R01 · FY2023 · CA

NanoOptogenetic immunotherapy for B cell lymphoma

$447,986
Gang Han · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · CA

Allosteric inhibitors targeting oncogenic BRAF V600E dimers

$447,702
Evripidis Gavathiotis · Albert Einstein College Of Medicine · R01 · FY2021 · CA

ATF2 in DNA damage response.

$447,626
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2007 · CA

XAI-TRUST: Explainable AI Techniques to Rigorously Understand, Scrutinize, and Trust Clinical AI

$447,621
Su-In Lee · University Of Washington · R01 · FY2024 · EB

Brain tumors with regulatory T-cells treated with EGFRvIII-specific T-cells

$447,602
John H Sampson · Duke University · R01 · FY2017 · CA

Project 2: Combined CAR-T cell therapy

$447,559
Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA

Novel Mucosa-homing Dendritic Cell: Development, Trafficking and Function

$447,500
Eugene C Butcher · Palo Alto Veterans Instit For Research · R01 · FY2015 · AI

Developmental Funds

$447,466
Joann B Sweasy · University Of Arizona · P30 · FY2022 · CA

Androgen receptor regulation of reproductive function

$447,441
Elizabeth M. Wilson · Univ Of North Carolina Chapel Hill · R01 · FY2010 · HD

Interplay between tumor and microenvironment in bone metastasis

$447,407
Paul B Fisher · Virginia Commonwealth University · R01 · FY2024 · CA

Expanding the tumor antigen landscape and maintaining APCs in a T cell-activating state to restore tumor immunity

$447,162
Eduardo Davila · University Of Colorado Denver · R01 · FY2023 · CA

TREATING MELANOMA METASTASES WITH A NOVEL PHOTODYNAMIC APPROACH

$447,000
University Of Georgia Research Foundation, Inc. · · FY2015 · Department of Defense

PHARMACOLOGICAL TARGETING OF GALPHA SUBUNITS IN DISEASE

$446,968
Kendall Jay Blumer · Washington University · R01 · FY2020 · GM